Maynard Um
-
-
-
-
-
-
-
Wolfe Research Starts Structure Therapeutics (GPCR) at Peerperform
-
-
-
-
-
-
-
RBC: 'Our focus for LLY remains on the pending Orfo approval and subsequent launch'
-
-
-
-
-
-
-
Structure Therapeutics (GPCR) call put ratio 9.6 calls to 1 put with a focus on January and February calls as share price up 6.5%
-
-
-
-
-
-
-
Structure Therapeutics (GPCR) PT Raised to $100 at Citi, Removes Catalyst Watch
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Structure Therapeutics (GPCR)
-
-
-
-
-
-
-
Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Structure Therapeutics (GPCR)
-
405,280 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

